Thermo Fisher Wins 3 Oscars of Innovation, Shares Rise - Analyst Blog

By Zacks Equity Research,

Shutterstock photo

Massachusetts-based medical instruments manufacturer Thermo Fisher Scientific, Inc. ( TMO ) recently announced that it has procured the coveted R&D 100 Awards, widely recognized as the "Oscars of Innovation" for three of its scientific analytical instruments. These include Thermo Scientific Delta Ray, Thermo Scientific RIIDEye X and Thermo Scientific Dionex ERS 500.

Following the news, Thermo Fisher's share price gained 1.7% to eventually close at $121.00 on Friday.

The R&D Magazine is an online publication that makes available informative and technical articles to research scientists and interested technical associates across the globe. It sponsors the R&D 100 Awards, which identifies the top 100 revolutionary technologies introduced in the market each year.

Thermo Scientific Delta Ray

Thermo Fisher, in an attempt to provide better health care to its customers, is engaged in constant innovation of analytical instruments, lab equipments and specialty diagnostics that offer accurate and rapid patient outcomes. The Thermo Scientific Delta Ray is an isotope ratio infrared spectrometer (IRIS) which incorporates a universal reference interface (URI) and is utilized to scan volcanos, green house gases, plant ecology, and carbon capture and storage by scientists.  Its URI provides sample referencing and comparison of CO2  analyses.

This spectrometer, with the help of an optional dilution box, has the ability to analyze samples with CO2 concentration, ranging between 220 parts per million (ppm) to 100%. It has the potential to terminate complications that arise during transferring samples from the field to the lab and thus provides real-time outcomes to researchers.

Thermo Scientific RIIDEye X

This is an intuitive high performance radiation isotope identifier (RIID) that has been designed for fast and easy identification of gamma and neutron radiation sources. This handheld detector can accurately locate the presence, type and quantity of radioactive materials in real time, under harsh operating conditions.

This improved RIIDEye X can identify special materials after 30 seconds and is the only device that can survive 3-foot drops onto concrete. It is thus typically utilized by military personnel, first responders and field-based researchers, mostly in response to potential public health and safety threats.

Thermo Scientific Dionex ERS 500

The Thermo Scientific Dionex ERS 500 is a high capacity next generation ion chromatography (IC) suppressor that removes conductive ions from eluents by increasing analyte signaling. At the same time, it reduces background signal and noise. It is the first electrolytically regenerated suppressor that does not require any chemical reagent during IC analysis.

This high backpressure resilient suppressor is available in 2 mm and 4mm formats and can effectively analyze varied scale of IC applications. It improves peak efficiency, particularly when coupled with 4μm columns and has been devised for use in environmental, food and beverage, and pharmaceutical markets.

Management at Thermo Fisher is enthusiastic about the receipt of the R&D 100 Awards. Notably, Thermo Fisher's commitment toward technology development and innovation forms a crucial ingredient of its growth strategy.

Zacks Rank

Currently, Thermo Fisher carries a Zacks Rank #4 (Sell). Some better-ranked medical instrument stocks that warrant a look include Masimo Corporation ( MASI ), Accuray Incorporated ( ARAY ) and Heartware International Inc. ( HTWR ). While Masimo sports a Zacks Rank #1 (Strong Buy), Accuray and Heartware International hold a Zacks Rank #2 (Buy) each. 

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

THERMO FISHER (TMO): Free Stock Analysis Report

ACCURAY INC (ARAY): Free Stock Analysis Report

MASIMO CORP (MASI): Free Stock Analysis Report

HEARTWARE INTL (HTWR): Free Stock Analysis Report

To read this article on click here.

Zacks Investment Research

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

This article appears in: Investing , Business , Stocks
Referenced Stocks: URI , IC , TMO , ARAY , MASI

More from


Follow on:

Find a Credit Card

Select a credit card product by:
Select an offer:
Data Provided by